vs
FOSTER L B CO(FSTR)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是FOSTER L B CO的1.2倍($197.9M vs $160.4M),REPLIGEN CORP净利率更高(6.7% vs 1.5%,领先5.2%),FOSTER L B CO同比增速更快(25.1% vs 13.6%),FOSTER L B CO自由现金流更多($19.8M vs $17.6M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs 13.6%)
Foster L B Co.是一家总部位于美国的专业工业制造企业,主要生产销售工程通道产品、建筑组件及铁路基础设施用品,服务覆盖北美及部分全球地区的商业建筑、交通和工业领域客户。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
FSTR vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.2倍
$160.4M
营收增速更快
FSTR
高出11.5%
13.6%
净利率更高
RGEN
高出5.2%
1.5%
自由现金流更多
FSTR
多$2.3M
$17.6M
两年增速更快
RGEN
近两年复合增速
13.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $160.4M | $197.9M |
| 净利润 | $2.4M | $13.3M |
| 毛利率 | 19.7% | 52.5% |
| 营业利润率 | 4.9% | 9.0% |
| 净利率 | 1.5% | 6.7% |
| 营收同比 | 25.1% | 13.6% |
| 净利润同比 | 1098.3% | 143.9% |
| 每股收益(稀释后) | $0.22 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FSTR
RGEN
| Q4 25 | $160.4M | $197.9M | ||
| Q3 25 | $138.3M | $188.8M | ||
| Q2 25 | $143.6M | $182.4M | ||
| Q1 25 | $97.8M | $169.2M | ||
| Q4 24 | $128.2M | $174.1M | ||
| Q3 24 | $137.5M | $154.9M | ||
| Q2 24 | $140.8M | $154.1M | ||
| Q1 24 | $124.3M | $151.3M |
净利润
FSTR
RGEN
| Q4 25 | $2.4M | $13.3M | ||
| Q3 25 | $4.4M | $14.9M | ||
| Q2 25 | $2.9M | $14.9M | ||
| Q1 25 | $-2.1M | $5.8M | ||
| Q4 24 | $-242.0K | $-30.3M | ||
| Q3 24 | $35.9M | $-654.0K | ||
| Q2 24 | $2.8M | $3.3M | ||
| Q1 24 | $4.4M | $2.1M |
毛利率
FSTR
RGEN
| Q4 25 | 19.7% | 52.5% | ||
| Q3 25 | 22.5% | 53.2% | ||
| Q2 25 | 21.5% | 50.0% | ||
| Q1 25 | 20.6% | 53.6% | ||
| Q4 24 | 22.3% | 26.1% | ||
| Q3 24 | 23.8% | 50.0% | ||
| Q2 24 | 21.7% | 49.8% | ||
| Q1 24 | 21.1% | 49.5% |
营业利润率
FSTR
RGEN
| Q4 25 | 4.9% | 9.0% | ||
| Q3 25 | 6.0% | 8.9% | ||
| Q2 25 | 5.3% | 7.6% | ||
| Q1 25 | -2.0% | 3.9% | ||
| Q4 24 | 2.4% | -17.7% | ||
| Q3 24 | 5.3% | -5.1% | ||
| Q2 24 | 3.2% | 1.0% | ||
| Q1 24 | 4.5% | 1.3% |
净利率
FSTR
RGEN
| Q4 25 | 1.5% | 6.7% | ||
| Q3 25 | 3.1% | 7.9% | ||
| Q2 25 | 2.0% | 8.2% | ||
| Q1 25 | -2.2% | 3.4% | ||
| Q4 24 | -0.2% | -17.4% | ||
| Q3 24 | 26.1% | -0.4% | ||
| Q2 24 | 2.0% | 2.2% | ||
| Q1 24 | 3.6% | 1.4% |
每股收益(稀释后)
FSTR
RGEN
| Q4 25 | $0.22 | $0.24 | ||
| Q3 25 | $0.40 | $0.26 | ||
| Q2 25 | $0.27 | $0.26 | ||
| Q1 25 | $-0.20 | $0.10 | ||
| Q4 24 | $-0.04 | $-0.55 | ||
| Q3 24 | $3.27 | $-0.01 | ||
| Q2 24 | $0.26 | $0.06 | ||
| Q1 24 | $0.40 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $767.6M |
| 总债务越低越好 | $42.6M | $542.2M |
| 股东权益账面价值 | $175.3M | $2.1B |
| 总资产 | $330.4M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.24× | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
FSTR
RGEN
| Q4 25 | $4.3M | $767.6M | ||
| Q3 25 | $3.4M | $748.7M | ||
| Q2 25 | $4.2M | $708.9M | ||
| Q1 25 | $2.6M | $697.2M | ||
| Q4 24 | $2.5M | $757.4M | ||
| Q3 24 | $3.1M | $784.0M | ||
| Q2 24 | $4.0M | $809.1M | ||
| Q1 24 | $3.1M | $780.6M |
总债务
FSTR
RGEN
| Q4 25 | $42.6M | $542.2M | ||
| Q3 25 | $58.6M | $537.9M | ||
| Q2 25 | $81.4M | — | ||
| Q1 25 | $82.3M | — | ||
| Q4 24 | $46.8M | $525.6M | ||
| Q3 24 | $68.4M | — | ||
| Q2 24 | $87.0M | — | ||
| Q1 24 | $77.9M | — |
股东权益
FSTR
RGEN
| Q4 25 | $175.3M | $2.1B | ||
| Q3 25 | $174.8M | $2.1B | ||
| Q2 25 | $174.4M | $2.1B | ||
| Q1 25 | $170.8M | $2.0B | ||
| Q4 24 | $178.3M | $2.0B | ||
| Q3 24 | $181.9M | $2.0B | ||
| Q2 24 | $147.1M | $2.0B | ||
| Q1 24 | $144.6M | $2.0B |
总资产
FSTR
RGEN
| Q4 25 | $330.4M | $2.9B | ||
| Q3 25 | $333.9M | $2.9B | ||
| Q2 25 | $349.9M | $2.9B | ||
| Q1 25 | $342.8M | $2.9B | ||
| Q4 24 | $334.6M | $2.8B | ||
| Q3 24 | $344.5M | $2.8B | ||
| Q2 24 | $333.3M | $2.9B | ||
| Q1 24 | $326.4M | $2.8B |
负债/权益比
FSTR
RGEN
| Q4 25 | 0.24× | 0.26× | ||
| Q3 25 | 0.33× | 0.26× | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.26× | 0.27× | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | 0.59× | — | ||
| Q1 24 | 0.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $22.2M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $19.8M | $17.6M |
| 自由现金流率自由现金流/营收 | 12.3% | 8.9% |
| 资本支出强度资本支出/营收 | 1.5% | 4.1% |
| 现金转化率经营现金流/净利润 | 9.18× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $25.2M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
FSTR
RGEN
| Q4 25 | $22.2M | $25.7M | ||
| Q3 25 | $29.2M | $48.1M | ||
| Q2 25 | $10.4M | $28.6M | ||
| Q1 25 | $-26.1M | $15.0M | ||
| Q4 24 | $24.3M | $39.2M | ||
| Q3 24 | $24.7M | $49.3M | ||
| Q2 24 | $-5.0M | $42.2M | ||
| Q1 24 | $-21.4M | $44.7M |
自由现金流
FSTR
RGEN
| Q4 25 | $19.8M | $17.6M | ||
| Q3 25 | $26.4M | $43.4M | ||
| Q2 25 | $7.7M | $21.5M | ||
| Q1 25 | $-28.7M | $11.4M | ||
| Q4 24 | $22.3M | $33.6M | ||
| Q3 24 | $21.7M | $42.3M | ||
| Q2 24 | $-7.0M | $37.4M | ||
| Q1 24 | $-24.2M | $36.4M |
自由现金流率
FSTR
RGEN
| Q4 25 | 12.3% | 8.9% | ||
| Q3 25 | 19.1% | 23.0% | ||
| Q2 25 | 5.4% | 11.8% | ||
| Q1 25 | -29.4% | 6.8% | ||
| Q4 24 | 17.4% | 19.3% | ||
| Q3 24 | 15.8% | 27.3% | ||
| Q2 24 | -5.0% | 24.3% | ||
| Q1 24 | -19.4% | 24.0% |
资本支出强度
FSTR
RGEN
| Q4 25 | 1.5% | 4.1% | ||
| Q3 25 | 2.0% | 2.5% | ||
| Q2 25 | 1.9% | 3.9% | ||
| Q1 25 | 2.6% | 2.1% | ||
| Q4 24 | 1.5% | 3.2% | ||
| Q3 24 | 2.2% | 4.5% | ||
| Q2 24 | 1.5% | 3.1% | ||
| Q1 24 | 2.2% | 5.5% |
现金转化率
FSTR
RGEN
| Q4 25 | 9.18× | 1.93× | ||
| Q3 25 | 6.70× | 3.23× | ||
| Q2 25 | 3.61× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | -1.74× | 12.70× | ||
| Q1 24 | -4.83× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSTR
| Rail Technologies And Services Segment | $98.0M | 61% |
| Over Time Output Method | $26.3M | 16% |
| Services | $19.4M | 12% |
| Rail Technologies Products | $10.0M | 6% |
| Over Time Input Method | $8.3M | 5% |
RGEN
暂无分部数据